ARPA-H’s Renee Wegrzyn: “Success, for us, is that something translates into the real world.”

DOD Melanoma Research Program funding opportunities for FY24

The FY24 Defense Appropriations Act is anticipated to provide funding for the Melanoma Research Program to support innovative, high-impact melanoma research.

May 17, 2024

Vol.50 No.20

Conversation with The Cancer Letter

ARPA-H’s Andrew Carney: Join the AI Cyber Challenge to counter cyberattacks on health systems

Can AI-enabled technology safeguard hospitals, pharmacies, and medical devices from cyberattacks?

April 26, 2024

Vol.50 No.17

By Matthew Bin Han Ong

NCI Director's Report

Rathmell: To improve funding outlook, we must reverse distrust in science

With NCI funding expected to remain flat through fiscal year 2025, health professionals and leaders in oncology should use this time to amp up institutional efforts to collaborate and rebuild trust in science, NCI Director Kimryn Rathmell said.

April 12, 2024

Vol.50 No.15

By Matthew Bin Han Ong

Funding Opportunities

DOD Lung Cancer Research Program funding opportunities for FY24

The FY24 Defense Appropriations Act provides funding for the LCRP to support innovative, high-impact lung cancer research. The managing agent for the anticipated funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.

April 12, 2024

Vol.50 No.15